Purple Biotech : Immediate report on other matter -October 3

As filed with the Securities and Exchange Commission on October 30, 2023


Registration No. 333-


UNITED STATES


...

Related Keywords

United States , Israel , District Of Columbia , Washington , Lebanon , Tel Aviv Yafo , Tel Aviv , Gaza Strip , Rehovot , Hamerkaz , New York , Israeli , State Of Israel , American , Ricka Werner , Rockefeller Plaza , Jayun Koo , Sharon Rosen , Lior Fhima , Hc Wainwright Co , Bristol Myers Squibb , Tel Aviv Stock Exchange , Nasdaq , Drug Administration , Tyrnovo Ltd , Foreign Investment Company , Exchange Commission , Immunorizon Ltd , Purple Biotech Ltd , Famewave Ltd , Exchange Commission On , Primary Standard Industrial , Code Number , Chief Financial Officer , Menachem Begin , Securities Act , Financial Accounting Standards Board , Accounting Standards Codification , Registration Statement , Depositary Shares , American Depositary Share , October Warrants , Placement Agent Warrants , Securities Purchase Agreement , Nasdaq Capital Market , Ordinary Shares , Passive Foreign Investment Company , Qualified Electing Fund , Annual Report , Civil Liabilities , Purple Biotech , Purple Biotech Gmbh , New Israeli Shekels , Investigational New Drug Application , New Drug Application , Biologics License Application , Insulin Receptor Substrate , Signal Transducer , Tumor Associated Antigen , Registered Direct Offering , Concurrent Private Placement , October Warrant , October Offering , Registration Rights Agreements , Dilution Share , Science Park , Deposit Agreement , Statement Regarding Forward Looking Statements , Current Condition , Markets ,